Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-11-031026
Filing Date
2011-05-19
Accepted
2011-05-19 06:09:40
Documents
1
Period of Report
2010-12-14

Document Format Files

Seq Description Document Type Size
1 v223425_ex.html 4  
1 v223425_ex.xml 4 6683
  Complete submission text file 0001144204-11-031026.txt   8116
Mailing Address 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO, CA 92121
Business Address 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO, CA 92121 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 ANGELL BROOK DRIVE WEST BOYLSTON MA 01853
Business Address
ESBER HENRY JEMIL (Reporting) CIK: 0001391501 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22245 | Film No.: 11856319